Aunna Pourang
Dermatology · Fresno, CANPI 1225340268
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,040 and has fallen 56.8% since, to $881 in 2025.
Across 93 payments — averaging $46.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$737
- Johnson & Johnson$619
- AbbVie$397
- Dermavant Sciences, Inc.$357
- Biofrontera Inc.$241
- Galderma Laboratories, L.p.$207
- plus $2K from 21 others
Across 1 payment — averaging $3200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$3K
What the payments were for
- Food & beverage$4,336100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 13 | $737 |
| Johnson & Johnson(2 entities) | 13 | $619 |
| AbbVie(2 entities) | 16 | $397 |
| Dermavant Sciences, Inc. | 3 | $357 |
| Biofrontera Inc. | 6 | $241 |
| Galderma Laboratories, L.p. | 3 | $207 |
| Janssen Scientific Affairs, LLC | 3 | $183 |
| UCB, Inc. | 3 | $170 |
| Lilly USA, LLC | 3 | $158 |
| Krystal Biotech Inc | 3 | $148 |
| Sun Pharmaceutical Industries Inc. | 2 | $142 |
| Boehringer Ingelheim | 2 | $129 |
| Mallinckrodt Hospital Products Inc. | 1 | $126 |
| Organon | 1 | $116 |
| Pfizer | 2 | $113 |
| Sanofi | 1 | $86 |
| Chiesi USA, Inc. | 3 | $66 |
| Organogenesis Inc. | 3 | $64 |
| Novartis | 2 | $57 |
| Incyte Corporation | 2 | $50 |
| Amgen | 2 | $32 |
| Fresenius Kabi USA, LLC | 1 | $29 |
| Surgenex LLC | 1 | $24 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,336 in reported general payments places this provider in the 65th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 43 | $1,838 |
| Betamethasone Dipropionate | 40 | $1,477 |
| Metronidazole | 26 | $1,465 |
| Ketoconazole | 88 | $1,202 |
| Clindamycin Phosphate | 37 | $867 |
| Triamcinolone Acetonide | 45 | $675 |
| Ammonium Lactate | 45 | $661 |
| Doxycycline Hyclate | 15 | $555 |
| Doxycycline Monohydrate | 18 | $333 |
| Minocycline Hcl | 17 | $312 |
| Hydrocortisone | 27 | $97 |
| Nystatin | 19 | $95 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Fresno
- John BoswellFresno$777K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.